Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 569

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

The Effect of Molecular Rapid Diagnostic Testing on Clinical Outcomes in Bloodstream Infections: A Systematic Review and Meta-analysis

Open access
Timbrook, Tristan T., Morton, Jacob B., McConeghy, Kevin W., Caffrey, Aisling R., Mylonakis, Eleftherios, LaPlante, Kerry L. · 2017 · Clinical Infectious Diseases

Abstract

BACKGROUND: Previous reports on molecular rapid diagnostic testing (mRDT) do not consistently demonstrate improved clinical outcomes in bloodstream infections (BSIs). This meta-analysis seeks to evaluate the impact of mRDT in improving clinical outcomes in BSIs. METHODS: We searched PubMed, CINAHL, Web of Science, and EMBASE through May 2016 for BSI studies comparing clinical outcomes between mRDT and conventional microbiology methods. RESULTS: Thirty-one studies were included with 5920 patients. The mortality risk was significantly lower with mRDT than with conventional microbiology methods (odds ratio [OR], 0.66; 95% confidence interval [CI], .54-.80), yielding a number needed to treat of 20. The mortality risk was slightly lower with mRDT in studies with antimicrobial stewardship programs (ASPs) (OR, 0.64; 95% CI, .51-.79), and non-ASP studies failed to demonstrate a significant decrease in mortality risk (0.72; .46-1.12). Significant decreases in mortality risk were observed with both gram-positive (OR, 0.73; 95% CI, .55-.97) and gram-negative organisms (0.51; .33-.78) but not yeast (0.90; .49-1.67). Time to effective therapy decreased by a weighted mean difference of -5.03 hours (95% CI, -8.60 to -1.45 hours), and length of stay decreased by -2.48 days (-3.90 to -1.06 days). CONCLUSIONS: For BSIs, mRDT was associated with significant decreases in mortality risk in the presence of a ASP, but not in its absence. mRDT also decreased the time to effective therapy and the length of stay. mRDT should be considered as part of the standard of care in patients with BSIs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/ciw649

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 4

  1. 10.1016/j.jhin.2009.12.006 · doi:10.1016/j.jhin.2009.12.006
  2. Macvane SH , Nolte FS . Clinical impact of adding a rapid PCR-based blood culture identification panel (BCID) to an established antimicrobial stewardship intervention (ASI) program for patients with gram-negative bacteremia (GNB). [abstract 123]. In: Program and abstracts of the 55th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego, CA). 2015.
  3. Maslonka M , Freifeld AG , Rupp ME et al . Impact of rapid bloodstream pathogen identification in hospitalized patients [abstract P171]. In: Program and abstracts of IDWeek (Philadelphia, PA). 2014. · doi:10.1093/ofid/ofu052.37
  4. 10.1128/JCM.00104-15 · doi:10.1128/jcm.00104-15

Cited by

See all 569

Metadata

Authors
Timbrook, T. T., Morton, J. B., McConeghy, K. W., Caffrey, A. R., Mylonakis, E., & LaPlante, K. L.
Venue
Clinical Infectious Diseases
Published
2016-09-26
Volume
64
Issue
1
Pages
15-23
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2525326149
Cited by
569
References
40
FWCI
7.15
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.